RUNDC3B, SCG2, SLC1A3, EXT1 (as well as RHOBTB3, TSPAN7, CAV2, MLPH) were part of the NF2/SMARCB1 expression subclass of a recent study on genomic profiling of meningioma. Here, NF2 is linked to meningioma.